Madrigal MAESTRO Phase 3 NASH Trials Continue without Protocol Modifications; New Data Demonstrate that Reductions in Liver Fat Achieved by Resmetirom Predict NASH Resolution and Fibrosis Reduction

Suma Ramadas, PhD
Medical Affairs

Stacey Gandler
Brand Nourishment

Paul Theisen
Patient Acquisition

Joey Cohen
Medication Adherence

Frank Burrell
Scientific Storytelling

Pat Purcell
Meeting Engagement

Brenda Snow
Authentic Patient Voice

Matt Turner
Patient Affordability

Daniel Sontupe
Market Access

Bud Bilanich
Success Coach

Liz Kane
Impactful Strategy

Amy Giles
Increasing Engagement

David Linetsky
Point-of-Care Marketing

Matthew Durham
Omnidynamic Marketing